Bone Biologics Corp. | |
Stock Exchange | Other OTC |
EPS |
$0.57 |
Market Cap |
$362.53 M |
Shares Outstanding |
29 M |
Public Float |
1.64 M |
Address |
2 Burlington Woods Drive Burlington Massachusetts 01803 United States |
Employees | - |
Website | http://www.bonebiologics.com |
Updated | 07/08/2019 |
Bone Biologics Corp. is an emerging growth company, which engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA. |